Indian Journal of Surgery

, Volume 80, Issue 1, pp 54–60 | Cite as

The Charlson Comorbidity Index as an Independent Prognostic Factor in Older Colorectal Cancer Patients

  • Tetsuro Tominaga
  • Takashi Nonaka
  • Hiroaki Takeshita
  • Masaki Kunizaki
  • Yorihisa Sumida
  • Shigekazu Hidaka
  • Terumitsu Sawai
  • Takeshi Nagayasu
Original Article

Abstract

High-age patients have higher rates of comorbidity that are associated with a poor prognosis. It is important to correctly evaluate their preoperative status to avoid mortality. The aim of this study was to clarify whether the Charlson comorbidity index (CCI) was useful for predicting postoperative outcomes. This retrospective study collected data from 250 consecutive patients over 75 years of age. The CCI takes into account 19 comorbid conditions. Inflammation-based scores, including the Glasgow prognostic score (GPS) and the platelet to lymphocyte ratio (PLR), are other preoperative scoring systems. The relationships among these scores and postoperative outcomes were evaluated. The patients were classified according to their vital status (dead, n = 30 or alive, n = 220). Comorbidities, the presence of double cancer, and lymph node metastases were significantly different between the groups (p < 0.01, p = 0.01, and p < 0.01). In regard to the scoring systems, the CCI, GPS, and PLR were significantly different (p = 0.02, p = 0.03, and p = 0.05). Multivariate analysis identified CCI ≥ 2 (hazard ratio (HR) = 5.24, 95 % confidence interval (CI) = 1.30–12.1, p = 0.01) as a significant determinant of postoperative outcome (p < 0.01). The overall survival tended to be lower in patients with high CCI scores group (p = 0.03). The CCI was useful to predict postoperative outcomes in high-age colorectal cancer patients.

Keywords

Charlson comorbidity index Colorectal cancer Older patients Overall survival 

Notes

Compliance with Ethical Standards

The work presented herein is original, has not been previously published in whole or in part, and is not under consideration for publication at any other journal.

Conflicts of Interest

No financial or other potential conflicts of interest exist for any of the authors.

Financial Disclosure

None.

Supplementary material

12262_2016_1544_MOESM1_ESM.docx (15 kb)
ESM 1 (DOCX 14 kb)

References

  1. 1.
    Teriokhin AT, Budilova EV, Thomas F, et al. (2004) World wide variation in life-span sexual dimorphism and sex-specific environmental mortality rates. Hum Biol 76:623–641CrossRefPubMedGoogle Scholar
  2. 2.
    Alves A, Panis Y, Mathieu P, et al. (2005) Postoperative mortality and morbidity in French patients undergoing colorectal surgery: result of a prospective multicenter study. Arch Surg 140:278–283CrossRefPubMedGoogle Scholar
  3. 3.
    Mary EC, Peter P, Kathy LA, et al. (1987) A new method of classifying prognostic comorbity in longitudinal studies: development and validation. J Chron Dis 40:373–383CrossRefGoogle Scholar
  4. 4.
    Trinchieri G (2012) Cancer and inflammation: an old intuition with rapidly evolving new concept. Annu Rev Immunol 30:677–706CrossRefPubMedGoogle Scholar
  5. 5.
    Triantafillidis JK, Nasioulas G, Kosmidis PA (2009) Colorectal cancer and inflammatory bowel disease: epidemiology,risk factors, mechanism of carcinogenesis and prevention strategies. Anticancer Res 29:2727–2737PubMedGoogle Scholar
  6. 6.
    Marnell L, Mold C, Du Cos TW (2005) C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 117:104–111CrossRefPubMedGoogle Scholar
  7. 7.
    McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12:223–226CrossRefPubMedGoogle Scholar
  8. 8.
    Roxburgh CS, McMillan DC (2010) Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6:146–163CrossRefGoogle Scholar
  9. 9.
    Xie X, Luo KJ, Hu Y, et al. (2014) Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell carcinoma. Di Esophagus 19:10Google Scholar
  10. 10.
    Trousseau A, Phlegmasia AD (1865) Lectures on clinical medicine, delivered at the Holte-Dieu. Paris 5:281–332Google Scholar
  11. 11.
    Katayama J, Yasuda K, Kawai K, et al. (2011) Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer. BMC Cancer 11:16CrossRefGoogle Scholar
  12. 12.
    Ceze N, Thibault G, Goujoin G, et al. (2011) Pretreatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy. Cancer Chemother Pharmacol 68:1305–1313CrossRefPubMedGoogle Scholar
  13. 13.
    Birim O, Kappetein AP, Bogers AJ (2005) Charlson cormorbidity index as a predictor of long term outcome after surgery for non-small cell lung cancer. Eur J Cardiothoracic Surg 28:759–762CrossRefGoogle Scholar
  14. 14.
    Smith RA, Bosonnet L, Raraty M, et al. (2009) Preoperative platelet lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg 197:466–472CrossRefPubMedGoogle Scholar
  15. 15.
    McMillan DC, Crozier JE, Canna K, et al. (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectum cancer. Int J Color Dis 22:881–886CrossRefGoogle Scholar
  16. 16.
    Santos DD, Ferrone CR, Sheng H, et al. (2015) The Charlson age comorbidity index predicts early mortality after surgery for pancreatic cancer. Sirgery 157:881–887Google Scholar
  17. 17.
    Wu CC, Hsu TW, Chang CM, et al. (2015) Age-adjusted Charlson comorbidity index scores as predictor of survival in colorectal cancer patients who underwent surgical resection and chemoradiation. Medicine 94:431CrossRefGoogle Scholar
  18. 18.
    Haga Y, Ikei S, Ogawa M (1999) Estimation of physiologic ability and surgical stress (E-PASS) as a new prediction scoring system for postoperative morbidity and mortality following elective gastrointestinal surgery. Surg Today 29:219–225CrossRefPubMedGoogle Scholar
  19. 19.
    Prytherch DR, Whiteley MS, Higgins B, et al. (1998) POSSUM and Portsmouth POSSUM for predicting mortality. Physiological and operative severity score for the enumeration of mortality and morbidity. Br J Surg 85:1217–1220CrossRefPubMedGoogle Scholar
  20. 20.
    Forrest LM, McMillan DC, McArdle CS, et al. (2003) Evaliiation of cumulative prognostic scores based on the systemic inflammatory response I patients with inoperable non-small-cell lung cancer. Br J Cancer 89:1028–1030CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Choi KW, Hong SW, Chang YG, et al. (2014) Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients. Ann Surg Treat Res 86:309–313CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Aparecida SC, Fattori A, Sousa AL, et al. (2010) Determining the C-reactive protein level in patients with different clinical forms of Chagas disease. Rev Esp Cardiol 63:1096–1099CrossRefGoogle Scholar
  23. 23.
    McMillan DC, Canna K, McArdle CS (2003) Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 90:215–219CrossRefPubMedGoogle Scholar
  24. 24.
    Cheng CC, Sun CF, Pai Wang WK, et al. (2010) Preoperative serum C-reactive protein and gastric cancer ; clinical-pathological correlation and prognostic significace. Chang Gung Med J 33:301–311Google Scholar
  25. 25.
    Cooper JK, Gardner C (1989) Effect of aging on serum albumin. J Am Geriaty Soc 37:1039–1042CrossRefGoogle Scholar
  26. 26.
    Gom I, Fukushima H, Shiraki M, et al. (2007) Relationship between serum albumin level and aging in community-dwelling self-supported elderly populations. J Nutr Sci Vitaminol 53:37–42CrossRefPubMedGoogle Scholar
  27. 27.
    Sahyoun NR, Jacques PF, Dallal G, et al. (1996) Use of albumin as a predictor of mortality in community dwelling and institutionalized elderly populations. J Clin Epidemiol 49:981–988CrossRefPubMedGoogle Scholar
  28. 28.
    Cabrerizo S, Cuadras D, Gomez-Busto F, et al. (2015) Serum albumin and health in older people: review and meta analysis. Maturitas 81:17–27CrossRefPubMedGoogle Scholar
  29. 29.
    Kwon HC, Kim SH, Oh SY (2012) Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers 17:216–222CrossRefPubMedGoogle Scholar
  30. 30.
    Jain S, Harris J, Ware J (2010) Platelets: linking hemostasis and cancer. Arterioscler Thromb Vasc Biol 30:2362–2367CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Association of Surgeons of India 2016

Authors and Affiliations

  • Tetsuro Tominaga
    • 1
  • Takashi Nonaka
    • 1
  • Hiroaki Takeshita
    • 1
  • Masaki Kunizaki
    • 1
  • Yorihisa Sumida
    • 1
  • Shigekazu Hidaka
    • 1
  • Terumitsu Sawai
    • 2
  • Takeshi Nagayasu
    • 1
  1. 1.Department of Surgical Oncology, Graduate School of Biomedical ScienceNagasaki UniversityNagasakiJapan
  2. 2.Department of Cardiopulmonary Rehabilitation Science, Graduate School of Biomedical ScienceNagasaki UniversityNagasakiJapan

Personalised recommendations